School of Medicine, Mae Fah Luang University, 365 Moo 12, Nang Lae, Mueang Chiang Rai District, Chiang Rai, 57100, Thailand.
Cancer and Immunology Research Unit (CIRU), Mae Fah Luang University, Chiang Rai, 57100, Thailand.
J Mol Histol. 2024 Dec;55(6):1177-1197. doi: 10.1007/s10735-024-10258-6. Epub 2024 Sep 4.
Type 2 diabetes mellitus (T2DM) is a global health concern with increasing prevalence. Mathurameha, a Thai herbal formula, has shown promising glucose-lowering effects and positive impacts on biochemical profiles in diabetic rats. The present study investigated the protective effects of Mathurameha on cardiovascular complications in high-fat diet/streptozotocin (HFD/STZ)-induced type 2 diabetic rats using histological and proteomic analyses. Thirty-five male Sprague-Dawley rats were divided into seven groups: normal diet (ND), ND with aqueous extract (ND + AE450), ND with ethanolic extract (ND + EE200), diabetes (DM), DM with AE (DM + AE450), DM with EE (DM + EE200), and DM with metformin (DM + Met). Mathurameha, especially at 200 mg/kg EE, significantly reduced adipocyte size, cardiac and vascular abnormalities, collagen deposition, and arterial wall thickness in DM rats. Proteomic analysis of rat aortas revealed 30 significantly altered proteins among the ND, DM, and DM + EE200 groups. These altered proteins are involved in various biological processes related to diabetes. Biochemical assays showed that Mathurameha reduced lipid peroxidation (MDA), increased antioxidant levels (GSH), and decreased the expression of inflammatory markers (ICAM1, TNF-α). In conclusion, Mathurameha exhibited significant protective effects against cardiovascular complications in HFD/STZ-induced type 2 diabetic rats through its antioxidant and anti-inflammatory properties.
2 型糖尿病(T2DM)是一种全球健康关注的疾病,其患病率不断上升。泰国草药配方 Mathurameha 已显示出有希望的降血糖作用,并对糖尿病大鼠的生化谱产生积极影响。本研究通过组织学和蛋白质组学分析,研究了 Mathurameha 对高脂肪饮食/链脲佐菌素(HFD/STZ)诱导的 2 型糖尿病大鼠心血管并发症的保护作用。35 只雄性 Sprague-Dawley 大鼠分为 7 组:正常饮食(ND)、ND 加水性提取物(ND+AE450)、ND 加乙醇提取物(ND+EE200)、糖尿病(DM)、DM 加 AE(DM+AE450)、DM 加 EE(DM+EE200)和 DM 加二甲双胍(DM+Met)。Mathurameha,特别是 200mg/kg EE,显著减少了 DM 大鼠的脂肪细胞大小、心脏和血管异常、胶原蛋白沉积和动脉壁厚度。大鼠主动脉的蛋白质组学分析显示,ND、DM 和 DM+EE200 组之间有 30 种明显改变的蛋白质。这些改变的蛋白质涉及与糖尿病相关的各种生物学过程。生化分析表明,Mathurameha 降低了脂质过氧化(MDA),增加了抗氧化剂水平(GSH),并降低了炎症标志物(ICAM1、TNF-α)的表达。总之,Mathurameha 通过其抗氧化和抗炎特性,对 HFD/STZ 诱导的 2 型糖尿病大鼠的心血管并发症表现出显著的保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025-7-24
Nat Rev Cardiol. 2023-10
Signal Transduct Target Ther. 2022-7-6
Immunity. 2022-1-11
Cell Metab. 2021-8-3